Hospitalization for respiratory syncytial virus in the paediatric population in Spain

Epidemiology and Infection

Volumn 131, Issue 2, 2003, Pages 867-872

  Vicente, D ^a   Montes, M ^a   Cilla, G ^a   Perez Yarza, E G ^a   Perez Trallero, E ^a,b  

^a HOSPITAL DONOSTIA   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ARTICLE; CHILD CARE; CHILD HOSPITALIZATION; COMMUNICABLE DISEASE; FREQUENCY ANALYSIS; HUMAN; INCIDENCE; INFANT; INFECTION PREVENTION; INTENSIVE CARE UNIT; LABORATORY DIAGNOSIS; LENGTH OF STAY; NOSE SMEAR; POPULATION RESEARCH; PRESCHOOL CHILD; PUBLIC HEALTH; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; SEASONAL VARIATION; SPAIN; VIRUS INFECTION;

CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; LENGTH OF STAY; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPAIN;

EID: 0142242132     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268803008926     Document Type: Article

References (22)

1. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344: 1917-1928.
2. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000; 13: 371-384.
3. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn. Pediatrics 1998; 102: 1211-1216.
4. Simoes EA, Tan DH, Ohlsson A, Sales V, Wang EE. Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines. Vaccine 2001; 20: 954-960.
5. Crowe JE Jr. Respiratory syncytial virus vaccine development. Vaccine 2001 ; 20 (Suppl 1): S32-S37.
6. Carbonell-Estrany X, Quero J, Group TI. Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons. Pediatr Infect Dis J 2001 ; 20: 874-879.
7. Estadística de población y vivienda 1996. Padrón municipal de habitantes de 1996. Instituto Vasco de Estadística. Administración de la Comunidad Autónoma de Euskadi (Ed). Vitoria, 1996: 37-162.
8. Hall CB, Douglas RG Jr, Geiman JM. Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr 1976; 89: 11-15.
9. Menegus MA. Rapid systems and instruments for the identification of viruses. In: Truant AL, ed. Manual of commercial methods in clinical microbiology, 1st edn. Washington, USA: ASM Press, 2002: 84-99.
10. Stockton J, Ellis JS, Saville M, Clewley JP, Zambon MC. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. J Clin Microbiol 1998; 36: 2990-2995.
11. Kristensen K, Dahm T, Frederiksen PS, et al. Epidemiology of respiratory syncytial virus infection requiring hospitalization in East Denmark. Pediatr Infect Dis J 1998; 17: 996-1000.
12. Weigl JA, Puppe W, Schmitt HJ. Incidence of respiratory syncytial virus-positive hospitalizations in Germany. Eur J Clin Microbiol Infect Dis 2001; 20: 452-459.
13. Cilla G, Perez-Trallero E, Piñeiro LD, Iturzaeta A, Vicente D. Hospitalizations for rotavirus gastroenteritis in Gipuzkoa (Basque country), Spain. Emerg Infect Dis 1999; 5: 834-835.
14. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282: 1440-1446.
15. Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr 2000; 137: 865-870.
16. Muller-Pebody B, Edmunds WJ, Zambon MC, Gay NJ, Crowcroft NS. Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998. Epidemiol Infect 2002; 129: 99-106.
17. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140: 543-546.
18. Waris M. Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B. J Infect Dis 1991; 163: 464-469.
19. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342: 232-239.
20. Hall CB, Walsh EE, Schnabel KC, Long CE, McConnochie KM, Hildreth SW, Anderson LJ. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis 1990; 162: 1283-1290.
21. Peret TC, Hall CB, Schnabel KC, Golub JA, Anderson LJ. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol 1998; 79: 2221-2229.
22. Wright PF. Generic protocol to examine the incidence of lower respiratory infection due to respiratory syncytial virus in children less than five years of age. 2000 WHO/V&B/00.08. Available at: http://www.who.int/vaccines-documents/DocsPDF99/www9906.pdf.